Tuesday, 29 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14499
Articles
Company
Drug
NMPA Approves Mabwell’s 8MW0511 for Febrile Neutropenia Prevention
May 30, 2025
Company
Drug
Hinova’s Deutenzalutamide Approved for Metastatic Prostate Cancer in China
May 30, 2025
Company
Drug
Sino Biopharmaceutical’s TQB2868 Shows Strong Results in Phase II Pancreatic Cancer Trial
May 30, 2025
Company
Drug
Hansoh Pharma Gains NMPA Clinical Approvals for HS-10510, HS-10542, and HS-20118
May 30, 2025
Company
Drug
Genor Biopharma Gains NMPA Approval for CDK4/6 Inhibitor Lerociclib in China
May 30, 2025
Company
Deals
Astellas Pharma Licenses Evopoint’s CLDN18.2 ADC for Global Development
May 30, 2025
Company
Deals
Danaher Partners with AstraZeneca to Advance Precision Medicine
May 30, 2025
Company
Drug
Innovent Biologics Doses First Patient in Phase III Psoriasis Trial for Picankibart
May 30, 2025
Company
Drug
GSK Halts PIVOT-PO Trial Early as Tebipenem HBr Meets Efficacy Targets for cUTI
May 30, 2025
Company
Drug
Amoytop Biotech Wins NMPA Approval for Weekly Inpegsomatropin in Pediatric Growth Deficiency
May 30, 2025
Company
Drug
Regend Therapeutics Gains NMPA Approval for Phase I/II Study of REGEND003 in Diabetes-Related CKD
May 30, 2025
Company
Deals
Ganzhou Hemay Pharma Files for HK IPO with SDIC Securities Sponsorship
May 30, 2025
1
2
…
352
353
354
355
356
…
1,208
1,209
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
